Evidence map›Paper›PMID 25900325›Full record

ArticleProteomics2015

Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.

Uri R Mbonye, Benlian Wang, Giridharan Gokulrangan, Mark R Chance, Jonathan Karn

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proteomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. CDK9 keeps RNA polymerase II on track.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. P-TEFb as A Promising Therapeutic Target.Molecules (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Uri R MbonyeDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Benlian WangCenter for Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Giridharan GokulranganCenter for Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Mark R ChanceCenter for Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Jonathan KarnDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Case Western Reserve University · USUniversity School · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Using NK Cells to eliminate the latent HIV reservoirU19AI096113 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PETERLIN, BORIS MATIJA · 2011 to 2015
$39.5M
Manipulating Epigenetic Control Mechanisms to Control HIV TranscriptionDP1DA028869 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2009 to 2013
$3.9M
Molecular mechanisms regulating HIV entry and exit from latencyR01AI067093 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2007 to 2011
$1.9M
NCATS NIH HHS UL1 TR000439NIAID NIH HHS P30 AI036219NIAID NIH HHS P30-AI036219NIAID NIH HHS R01 AI067093NIAID NIH HHS R01-AI067093NIAID NIH HHS U19 AI096113NIAID NIH HHS U19-AI096113NIDA NIH HHS DP1 DA028869NIDA NIH HHS DP1-DA028869
6 · The paper itself

Abstract

Efficient HIV transcription requires P-TEFb, an essential co-factor for Tat. In actively replicating cells, P-TEFb is incorporated into the 7SK snRNP complex together with the repressor protein HEXIM1. Using an affinity purification-tandem mass spectrometry approach to identify modification sites on HEXIM1 that regulate the sequestration of P-TEFb by 7SK snRNP, we found that HEXIM1 can be phosphorylated on adjacent residues in a region immediately upstream of the coiled-coil dimerization domain (Ser268, Thr270, Tyr271, and Tyr274). Phosphomimetic mutations of Tyr271 and Tyr274 disrupted the assembly of P-TEFb and HEXIM1 into the 7SK snRNP complex. Although Y271E/Y274E did not adversely affect the nuclear localization pattern of HEXIM1, it induced the redistribution of the CDK9 subunit of P-TEFb into the cytoplasm. By contrast, the Y271F/Y274F HEXIM1 mutant assembled normally with P-TEFb within the 7SK snRNP complex but severely reduced proviral gene expression in T cells in response to activation signals and caused a severe growth defect of Jurkat T cells. Thus, Y271F/Y274F, which cannot be phosphorylated on these residues, appears to block the exchange of active P-TEFb from the 7SK complex, thereby limiting the level of P-TEFb below the threshold required to support transcription elongation of the HIV provirus and cellular genes.

Indexed as

Amino Acid SequenceBlotting, WesternCells, CulturedChromatography, LiquidGene Expression Regulation, ViralHEK293 CellsHIV-1HIV InfectionsHumansImmunoprecipitationJurkat CellsMolecular Sequence DataMutationPhosphorylationPositive Transcriptional Elongation Factor BProtein BindingHEXIM1 protein, humanPositive Transcriptional Elongation Factor BRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA, Small NuclearTranscription FactorsViral Proteins7SK RNP complexHEXIM1 phosphorylationHIV TatMicrobiologyP-TEFb

Identifiers

PMID25900325
PMCPMC4487608
OpenAlexW1994817306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.